文献速递神经肿瘤

优化海绵窦脑膜瘤的管理:整合内镜经鼻与经眶手术及辅助立体定向放疗的新策略

Optimizing Management of Cavernous Sinus Meningiomas: A Novel Strategy Integrating Endoscopic Endonasal and Transorbital Surgery with Adjuvant Stereotactic Radiotherapy.
PubMed 文献 · World Neurosurg · 2024-09-05

回顾性研究纳入39例症状性海绵窦脑膜瘤患者,采用内镜经鼻和/或经眶手术联合辅助立体定向放疗。术后颅神经3-6功能缺损恢复率60.9%,视力恢复率65%,平均随访44个月肿瘤进展4例(10.3%)。作者认为该策略安全有效。

要点

  • 内镜经鼻入路24例(61.5%),经眶入路10例(25.6%),联合入路5例(12.8%)。
  • 术后颅神经3-6缺损恢复率60.9%,视力恢复率65%。
  • 平均随访44个月,肿瘤进展4例(10.3%),其中WHO II级3例、WHO I级1例。

核心结论

  • 本研究支持对症状性海绵窦脑膜瘤采用内镜颅底手术联合辅助立体定向放疗,显示安全有效。
  • 该策略在症状改善、肿瘤控制和安全性方面取得良好结果。

研究设计与样本

  • 回顾性研究,复习2017年1月至2022年4月在本机构接受内镜经鼻和/或经眶手术并辅助立体定向放疗的症状性海绵窦脑膜瘤患者的医疗记录。
  • 共纳入39例海绵窦脑膜瘤患者。

主要发现

  • 内镜经鼻入路24例(61.5%),内镜经眶入路10例(25.6%),联合入路5例(12.8%)。
  • 79.5%的患者接受了辅助立体定向放疗。
  • 术后颅神经3-6缺损恢复率为60.9%,视力恢复率为65%。
  • 并发症包括术后颅神经3-6缺损5例和放疗后视力下降1例。
  • 平均随访44个月,肿瘤进展4例(10.3%),其中3例为WHO II级脑膜瘤,1例为WHO I级。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cavernous sinus meningiomas (CSMs) are challenging skull base tumors due to their proximity to vital neurovascular structures. Traditional aggressive transcranial resection often leads to significant morbidities with limited improvement of cranial nerve (CN) deficits. Recent advancements in endoscopic skull base surgery and stereotactic radiation therapy (SRT) offer a more conservative approach, facilitating tumor decompression while preserving critical structures. METHODS: This retrospective study reviewed medical records of patients with symptomatic CSMs who underwent endoscopic endonasal and/or transorbital surgery, followed by adjuvant SRT, at our institution between January 2017 and April 2022. Patient demographics, tumor characteristics, surgical approaches, radiation, treatment outcomes, complications, and follow-up time were analyzed. RESULTS: Thirty-nine patients with CSMs were included. Endoscopic endonasal approach was performed in 24 patients (61.5%), endoscopic transorbital approach in 10 patients (25.6%), and combined approaches in 5 patients (12.8%). Adjuvant SRT was administered to 79.5% of patients. Postoperative outcomes showed recovery of CN 3-6 deficits and vision in 60.9% and 65% of cases, respectively. Complications included postoperative CN 3-6 deficits in 5 cases and postradiation visual deterioration in 1 case. During a mean follow-up period of 44 months, tumor progression occurred in 4 patients (10.3%), with 3 diagnosed as World Health Organization grade II meningiomas and 1 as World Health Organization grade I. CONCLUSIONS: This study supports the use of endoscopic skull base surgery combined with adjuvant SRT for symptomatic CSMs, demonstrating both safety and efficacy. This approach yielded favorable outcomes in symptom improvement, tumor control, and positive safety profile.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Noiphithak R, Yanez-Siller JC, Nimmannitya P, et al. Optimizing Management of Cavernous Sinus Meningiomas: A Novel Strategy Integrating Endoscopic Endonasal and Transorbital Surgery with Adjuvant Stereotactic Radiotherapy. World Neurosurg. 2024. PMID: 39243965. doi:10.1016/j.wneu.2024.08.164

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。